Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²)

The Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²), established in 2023, was created to advance the understanding of cannabis and its derivatives, often referred to as cannabinoids. This innovative Center is a hub for groundbreaking research, dissemination of information, and education in the field of cannabis and cannabinoid science. Our mission is to conduct comprehensive research on the risks and potential therapeutic applications of cannabis and cannabinoids, and to inform public policy based on our findings.

At YC-SCAN², we focus on thorough scientific research and strive to find science-based answers to critical questions concerning the risks and potential medical benefits associated with cannabis and its derivatives. We are also dedicated to translating the knowledge we gain into helpful, practical applications that could enhance patient care and inform public policy.

The Center supports pilot projects from Yale-affiliated researchers, aiming to bridge the gap between basic and clinical research. These projects form the foundation for larger funding applications to NIH and other agencies. YC-SCAN² also encourages multidisciplinary studies into the effects of cannabis and cannabinoids, combining molecular neuroscience, genetics, electroencephalography, imaging, and psychopharmacology. We are deeply committed to training the next generation of scientists and clinicians to carry forward this important work in the emerging field of cannabis science.

Our Annual Report highlights the impactful work and achievements of the Research Center over the past year. Inside, you’ll find a detailed look at the studies we’ve conducted, the progress we’ve made in advancing cannabis and psychedelic science, and the collaborations that drive our mission forward. The report also offers a preview of what’s ahead—our goals, upcoming projects, and vision for the future of research, innovation, and community impact.

Download